KANJINTI trastuzumab 420 mg powder for injection vial, Amgen Australia Pty Ltd, CON-371
Product name
KANJINTI trastuzumab 420 mg powder for injection vial
Sponsor name
Amgen Australia Pty Ltd
Consent start
Consent no.
CON-371
Standard
Section 7(2)(d) in Therapeutic Goods Order No. 91 - Standard for labels of prescription and related medicines
Non-compliance with standard
The container label has text that is less than 1.5mm
Therapeutic product type
Prescription medicines